The association between increased FOSL1 expression and ESCC has been investigated, and the silencing of FOSL1 has been reported to have inhibitory effects on cell proliferation and invasion and confer protection against the cytotoxicity of cisplatin in ESCC cells.14 Here, FOSL1 is linked to esophageal squamous cell carcinoma.